An expressed retrogene of the master embryonic stem cell gene pou5f1 is associated with prostate cancer susceptibility

American Journal of Human Genetics

Volumn 94, Issue 3, 2014, Pages 395-404

  Breyer, Joan P ^a   Dorset, Daniel C ^a   Clark, Travis A ^a   Bradley, Kevin M ^a,b   Wahlfors, Tiina A ^c   McReynolds, Kate M ^a   Maynard, William H ^a   Chang, Sam S ^a   Cookson, Michael S ^a   Smith, Joseph A ^a   Schleutker, Johanna ^d   Dupont, William D ^a   Smith, Jeffrey R ^a,e  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

^b FOUNDATION FOR APPLIED MOLECULAR EVOLUTION   (United States)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^d UNIVERSITY OF TURKU   (Finland)

^e Veteran's Affairs Tennessee Valley Healthcare System   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OCTAMER TRANSCRIPTION FACTOR 4;

ARTICLE; AUTOREGULATION; CANCER RISK; CANCER SCREENING; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; EMBRYONIC STEM CELL; FAMILIAL CANCER; GENE EXPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC REGULATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE; HIGH RISK POPULATION; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; HUMAN TISSUE; MALE; OBSERVATIONAL STUDY; ONCOGENE; OPEN READING FRAME; POPULATION GENETICS; POU5F1 GENE; POU5F1B GENE; PREDICTION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE TISSUE; QUANTITATIVE TRAIT LOCUS; RETROGENE; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; TISSUES; ADULT; ALLELE; CANCER PROGNOSIS; GENE LINKAGE DISEQUILIBRIUM; GENOTYPE; MAJOR CLINICAL STUDY; MISSENSE MUTATION;

ADOLESCENT; ADULT; AGED; ALLELES; CASE-CONTROL STUDIES; CELL NUCLEUS; CELL TRANSFORMATION, NEOPLASTIC; DATABASES, GENETIC; EMBRYONIC STEM CELLS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; MUTATION, MISSENSE; OCTAMER TRANSCRIPTION FACTOR-3; OPEN READING FRAMES; PROSTATIC NEOPLASMS; QUANTITATIVE TRAIT LOCI; RISK; SEQUENCE ANALYSIS, DNA; TRANSCRIPTION, GENETIC; YOUNG ADULT;

EID: 84895921713     PISSN: 00029297     EISSN: 15376605     Source Type: Journal    
DOI: 10.1016/j.ajhg.2014.01.019     Document Type: Article

References (74)

1. S. Kastler, L. Honold, M. Luedeke, R. Kuefer, P. Möller, J. Hoegel, W. Vogel, C. Maier, and G. Assum POU5F1P1, a putative cancer susceptibility gene, is overexpressed in prostatic carcinoma Prostate 70 2010 666 674
2. Y. Atlasi, S.J. Mowla, S.A. Ziaee, P.J. Gokhale, and P.W. Andrews OCT4 spliced variants are differentially expressed in human pluripotent and nonpluripotent cells Stem Cells 26 2008 3068 3074
3. G. Cauffman, I. Liebaers, A. Van Steirteghem, and H. Van de Velde POU5F1 isoforms show different expression patterns in human embryonic stem cells and preimplantation embryos Stem Cells 24 2006 2685 2691
4. J. Lee, H.K. Kim, J.Y. Rho, Y.M. Han, and J. Kim The human OCT-4 isoforms differ in their ability to confer self-renewal J. Biol. Chem. 281 2006 33554 33565
5. J.R. Prensner, M.K. Iyer, O.A. Balbin, S.M. Dhanasekaran, Q. Cao, J.C. Brenner, B. Laxman, I.A. Asangani, C.S. Grasso, and H.D. Kominsky et al. Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression Nat. Biotechnol. 29 2011 742 749
6. B. Alaiyan, N. Ilyayev, A. Stojadinovic, M. Izadjoo, M. Roistacher, V. Pavlov, V. Tzivin, D. Halle, H. Pan, and B. Trink et al. Differential expression of colon cancer associated transcript1 (CCAT1) along the colonic adenoma-carcinoma sequence BMC Cancer 13 2013 196
7. A. Nissan, A. Stojadinovic, S. Mitrani-Rosenbaum, D. Halle, R. Grinbaum, M. Roistacher, A. Bochem, B.E. Dayanc, G. Ritter, and I. Gomceli et al. Colon cancer associated transcript-1: a novel RNA expressed in malignant and pre-malignant human tissues Int. J. Cancer 130 2012 1598 1606
8. S. Chung, H. Nakagawa, M. Uemura, L. Piao, K. Ashikawa, N. Hosono, R. Takata, S. Akamatsu, T. Kawaguchi, and T. Morizono et al. Association of a novel long non-coding RNA in 8q24 with prostate cancer susceptibility Cancer Sci. 102 2011 245 252
9. L.T. Amundadottir, P. Sulem, J. Gudmundsson, A. Helgason, A. Baker, B.A. Agnarsson, A. Sigurdsson, K.R. Benediktsdottir, J.B. Cazier, and J. Sainz et al. A common variant associated with prostate cancer in European and African populations Nat. Genet. 38 2006 652 658
10. G. Suo, J. Han, X. Wang, J. Zhang, Y. Zhao, Y. Zhao, and J. Dai Oct4 pseudogenes are transcribed in cancers Biochem. Biophys. Res. Commun. 337 2005 1047 1051
11. R.A. Eeles, Z. Kote-Jarai, G.G. Giles, A.A. Olama, M. Guy, S.K. Jugurnauth, S. Mulholland, D.A. Leongamornlert, S.M. Edwards, J. Morrison UK Genetic Prostate Cancer Study Collaborators British Association of Urological Surgeons' Section of Oncology UK ProtecT Study Collaborators Multiple newly identified loci associated with prostate cancer susceptibility Nat. Genet. 40 2008 316 321
12. U. Peters, S. Jiao, F.R. Schumacher, C.M. Hutter, A.K. Aragaki, J.A. Baron, S.I. Berndt, S. Bézieau, H. Brenner, K. Butterbach Colon Cancer Family Registry and the Genetics and Epidemiology of Colorectal Cancer Consortium Identification of genetic susceptibility loci for colorectal tumors in a genome-wide meta-analysis Gastroenterology 144 2013 799 807.e24
13. F.R. Schumacher, S.I. Berndt, A. Siddiq, K.B. Jacobs, Z. Wang, S. Lindstrom, V.L. Stevens, C. Chen, A.M. Mondul, and R.C. Travis et al. Genome-wide association study identifies new prostate cancer susceptibility loci Hum. Mol. Genet. 20 2011 3867 3875
14. G. Thomas, K.B. Jacobs, M. Yeager, P. Kraft, S. Wacholder, N. Orr, K. Yu, N. Chatterjee, R. Welch, and A. Hutchinson et al. Multiple loci identified in a genome-wide association study of prostate cancer Nat. Genet. 40 2008 310 315
15. I. Tomlinson, E. Webb, L. Carvajal-Carmona, P. Broderick, Z. Kemp, S. Spain, S. Penegar, I. Chandler, M. Gorman, W. Wood CORGI Consortium A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21 Nat. Genet. 39 2007 984 988
16. I.P. Tomlinson, E. Webb, L. Carvajal-Carmona, P. Broderick, K. Howarth, A.M. Pittman, S. Spain, S. Lubbe, A. Walther, K. Sullivan CORGI Consortium EPICOLON Consortium A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3 Nat. Genet. 40 2008 623 630
17. M. Yeager, N. Orr, R.B. Hayes, K.B. Jacobs, P. Kraft, S. Wacholder, M.J. Minichiello, P. Fearnhead, K. Yu, and N. Chatterjee et al. Genome-wide association study of prostate cancer identifies a second risk locus at 8q24 Nat. Genet. 39 2007 645 649
18. C.A. Haiman, L. Le Marchand, J. Yamamato, D.O. Stram, X. Sheng, L.N. Kolonel, A.H. Wu, D. Reich, and B.E. Henderson A common genetic risk factor for colorectal and prostate cancer Nat. Genet. 39 2007 954 956
19. M. Ghoussaini, H. Song, T. Koessler, A.A. Al Olama, Z. Kote-Jarai, K.E. Driver, K.A. Pooley, S.J. Ramus, S.K. Kjaer, E. Hogdall UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons' Section of Oncology UK ProtecT Study Collaborators Multiple loci with different cancer specificities within the 8q24 gene desert J. Natl. Cancer Inst. 100 2008 962 966
20. R.A. Eeles, Z. Kote-Jarai, A.A. Al Olama, G.G. Giles, M. Guy, G. Severi, K. Muir, J.L. Hopper, B.E. Henderson, C.A. Haiman UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons' Section of Oncology UK ProtecT Study Collaborators PRACTICAL Consortium Identification of seven new prostate cancer susceptibility loci through a genome-wide association study Nat. Genet. 41 2009 1116 1121
21. J. Gudmundsson, P. Sulem, D.F. Gudbjartsson, T. Blondal, A. Gylfason, B.A. Agnarsson, K.R. Benediktsdottir, D.N. Magnusdottir, G. Orlygsdottir, and M. Jakobsdottir et al. Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility Nat. Genet. 41 2009 1122 1126
22. J. Gudmundsson, P. Sulem, D.F. Gudbjartsson, G. Masson, B.A. Agnarsson, K.R. Benediktsdottir, A. Sigurdsson, O.T. Magnusson, S.A. Gudjonsson, and D.N. Magnusdottir et al. A study based on whole-genome sequencing yields a rare variant at 8q24 associated with prostate cancer Nat. Genet. 44 2012 1326 1329
23. J. Gudmundsson, P. Sulem, A. Manolescu, L.T. Amundadottir, D. Gudbjartsson, A. Helgason, T. Rafnar, J.T. Bergthorsson, B.A. Agnarsson, and A. Baker et al. Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24 Nat. Genet. 39 2007 631 637
24. R. Takata, S. Akamatsu, M. Kubo, A. Takahashi, N. Hosono, T. Kawaguchi, T. Tsunoda, J. Inazawa, N. Kamatani, and O. Ogawa et al. Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population Nat. Genet. 42 2010 751 754
25. I. Cheng, G.K. Chen, H. Nakagawa, J. He, P. Wan, C.C. Laurie, J. Shen, X. Sheng, L.C. Pooler, and A.T. Crenshaw et al. Evaluating genetic risk for prostate cancer among Japanese and Latinos Cancer Epidemiol. Biomarkers Prev. 21 2012 2048 2058
26. F. Liu, A.W. Hsing, X. Wang, Q. Shao, J. Qi, Y. Ye, Z. Wang, H. Chen, X. Gao, and G. Wang et al. Systematic confirmation study of reported prostate cancer risk-associated single nucleotide polymorphisms in Chinese men Cancer Sci. 102 2011 1916 1920
27. J. Xu, A.S. Kibel, J.J. Hu, A.R. Turner, K. Pruett, S.L. Zheng, J. Sun, S.D. Isaacs, K.E. Wiley, and S.T. Kim et al. Prostate cancer risk associated loci in African Americans Cancer Epidemiol. Biomarkers Prev. 18 2009 2145 2149
28. N. Ahmadiyeh, M.M. Pomerantz, C. Grisanzio, P. Herman, L. Jia, V. Almendro, H.H. He, M. Brown, X.S. Liu, and M. Davis et al. 8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC Proc. Natl. Acad. Sci. USA 107 2010 9742 9746
29. L. Jia, G. Landan, M. Pomerantz, R. Jaschek, P. Herman, D. Reich, C. Yan, O. Khalid, P. Kantoff, and W. Oh et al. Functional enhancers at the gene-poor 8q24 cancer-linked locus PLoS Genet. 5 2009 e1000597
30. K.B. Meyer, A.T. Maia, M. O'Reilly, M. Ghoussaini, R. Prathalingam, P. Porter-Gill, S. Ambs, L. Prokunina-Olsson, J. Carroll, and B.A. Ponder A functional variant at a prostate cancer predisposition locus at 8q24 is associated with PVT1 expression PLoS Genet. 7 2011 e1002165
31. M.M. Pomerantz, N. Ahmadiyeh, L. Jia, P. Herman, M.P. Verzi, H. Doddapaneni, C.A. Beckwith, J.A. Chan, A. Hills, and M. Davis et al. The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer Nat. Genet. 41 2009 882 884
32. M.M. Pomerantz, C.A. Beckwith, M.M. Regan, S.K. Wyman, G. Petrovics, Y. Chen, D.J. Hawksworth, F.R. Schumacher, L. Mucci, and K.L. Penney et al. Evaluation of the 8q24 prostate cancer risk locus and MYC expression Cancer Res. 69 2009 5568 5574
33. L. Prokunina-Olsson, and J.L. Hall No effect of cancer-associated SNP rs6983267 in the 8q24 region on co-expression of MYC and TCF7L2 in normal colon tissue Mol. Cancer 8 2009 96
34. S. Tuupanen, M. Turunen, R. Lehtonen, O. Hallikas, S. Vanharanta, T. Kivioja, M. Björklund, G. Wei, J. Yan, and I. Niittymäki et al. The common colorectal cancer predisposition SNP rs6983267 at chromosome 8q24 confers potential to enhanced Wnt signaling Nat. Genet. 41 2009 885 890
35. N.F. Wasserman, I. Aneas, and M.A. Nobrega An 8q24 gene desert variant associated with prostate cancer risk confers differential in vivo activity to a MYC enhancer Genome Res. 20 2010 1191 1197
36. I.H. Park, R. Zhao, J.A. West, A. Yabuuchi, H. Huo, T.A. Ince, P.H. Lerou, M.W. Lensch, and G.Q. Daley Reprogramming of human somatic cells to pluripotency with defined factors Nature 451 2008 141 146
37. K. Takahashi, and S. Yamanaka Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors Cell 126 2006 663 676
38. M. Wernig, A. Meissner, R. Foreman, T. Brambrink, M. Ku, K. Hochedlinger, B.E. Bernstein, and R. Jaenisch In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state Nature 448 2007 318 324
39. I. Panagopoulos, E. Möller, A. Collin, and F. Mertens The POU5F1P1 pseudogene encodes a putative protein similar to POU5F1 isoform 1 Oncol. Rep. 20 2008 1029 1033
40. K. Hochedlinger, Y. Yamada, C. Beard, and R. Jaenisch Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues Cell 121 2005 465 477
41. T. Hu, S. Liu, D.R. Breiter, F. Wang, Y. Tang, and S. Sun Octamer 4 small interfering RNA results in cancer stem cell-like cell apoptosis Cancer Res. 68 2008 6533 6540
42. B. Peng, B. Li, Y. Han, and C.I. Amos Power analysis for case-control association studies of samples with known family histories Hum. Genet. 127 2010 699 704
43. J. Schleutker, A.B. Baffoe-Bonnie, E. Gillanders, T. Kainu, M.P. Jones, D. Freas-Lutz, C. Markey, D. Gildea, E. Riedesel, and J. Albertus et al. Genome-wide scan for linkage in finnish hereditary prostate cancer (HPC) families identifies novel susceptibility loci at 11q14 and 3p25-26 Prostate 57 2003 280 289
44. J. Schleutker, M. Matikainen, J. Smith, P. Koivisto, A. Baffoe-Bonnie, T. Kainu, E. Gillanders, R. Sankila, E. Pukkala, and J. Carpten et al. A genetic epidemiological study of hereditary prostate cancer (HPC) in Finland: frequent HPCX linkage in families with late-onset disease Clin. Cancer Res. 6 2000 4810 4815
45. M. Stephens, N.J. Smith, and P. Donnelly A new statistical method for haplotype reconstruction from population data Am. J. Hum. Genet. 68 2001 978 989
46. Q. Li, J.H. Seo, B. Stranger, A. McKenna, I. Pe'er, T. Laframboise, M. Brown, S. Tyekucheva, and M.L. Freedman Integrative eQTL-based analyses reveal the biology of breast cancer risk loci Cell 152 2013 633 641
47. J. Mathieu, Z. Zhang, W. Zhou, A.J. Wang, J.M. Heddleston, C.M. Pinna, A. Hubaud, B. Stadler, M. Choi, and M. Bar et al. HIF induces human embryonic stem cell markers in cancer cells Cancer Res. 71 2011 4640 4652
48. P. Sotomayor, A. Godoy, G.J. Smith, and W.J. Huss Oct4A is expressed by a subpopulation of prostate neuroendocrine cells Prostate 69 2009 401 410
49. I. Ben-Porath, M.W. Thomson, V.J. Carey, R. Ge, G.W. Bell, A. Regev, and R.A. Weinberg An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors Nat. Genet. 40 2008 499 507
50. G. Fromont, J. Godet, A. Peyret, J. Irani, O. Celhay, F. Rozet, X. Cathelineau, and O. Cussenot 8q24 amplification is associated with Myc expression and prostate cancer progression and is an independent predictor of recurrence after radical prostatectomy Hum. Pathol. 44 2013 1617 1623
51. I.A. Adzhubei, S. Schmidt, L. Peshkin, V.E. Ramensky, A. Gerasimova, P. Bork, A.S. Kondrashov, and S.R. Sunyaev A method and server for predicting damaging missense mutations Nat. Methods 7 2010 248 249
52. P. Kumar, S. Henikoff, and P.C. Ng Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm Nat. Protoc. 4 2009 1073 1081
53. L.A. Boyer, T.I. Lee, M.F. Cole, S.E. Johnstone, S.S. Levine, J.P. Zucker, M.G. Guenther, R.M. Kumar, H.L. Murray, and R.G. Jenner et al. Core transcriptional regulatory circuitry in human embryonic stem cells Cell 122 2005 947 956
54. J.L. Chew, Y.H. Loh, W. Zhang, X. Chen, W.L. Tam, L.S. Yeap, P. Li, Y.S. Ang, B. Lim, P. Robson, and H.H. Ng Reciprocal transcriptional regulation of Pou5f1 and Sox2 via the Oct4/Sox2 complex in embryonic stem cells Mol. Cell. Biol. 25 2005 6031 6046
55. B. Li, V. Ruotti, R.M. Stewart, J.A. Thomson, and C.N. Dewey RNA-Seq gene expression estimation with read mapping uncertainty Bioinformatics 26 2010 493 500
56. D. Esch, J. Vahokoski, M.R. Groves, V. Pogenberg, V. Cojocaru, H. Vom Bruch, D. Han, H.C. Drexler, M.J. Araúzo-Bravo, and C.K. Ng et al. A unique Oct4 interface is crucial for reprogramming to pluripotency Nat. Cell Biol. 15 2013 295 301
57. L. Poliseno, L. Salmena, J. Zhang, B. Carver, W.J. Haveman, and P.P. Pandolfi A coding-independent function of gene and pseudogene mRNAs regulates tumour biology Nature 465 2010 1033 1038
58. N. Xu, T. Papagiannakopoulos, G. Pan, J.A. Thomson, and K.S. Kosik MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells Cell 137 2009 647 658
59. M.A. Badeaux, C.R. Jeter, S. Gong, B. Liu, M.V. Suraneni, J. Rundhaug, S.M. Fischer, T. Yang, D. Kusewitt, and D.G. Tang In vivo functional studies of tumor-specific retrogene NanogP8 in transgenic animals Cell Cycle 12 2013 2395 2408
60. J. Cao, L. Li, C. Chen, C. Lv, F. Meng, L. Zeng, Z. Li, Q. Wu, K. Zhao, and B. Pan et al. RNA interference-mediated silencing of NANOG leads to reduced proliferation and self-renewal, cell cycle arrest and apoptosis in T-cell acute lymphoblastic leukemia cells via the p53 signaling pathway Leuk. Res. 37 2013 1170 1177
61. D.J. Fairbanks, A.D. Fairbanks, T.H. Ogden, G.J. Parker, and P.J. Maughan NANOGP8: evolution of a human-specific retro-oncogene G3 (Bethesda) 2 2012 1447 1457
62. D.J. Fairbanks, and P.J. Maughan Evolution of the NANOG pseudogene family in the human and chimpanzee genomes BMC Evol. Biol. 6 2006 12
63. E.E. Ibrahim, R. Babaei-Jadidi, A. Saadeddin, B. Spencer-Dene, S. Hossaini, M. Abuzinadah, N. Li, W. Fadhil, M. Ilyas, D. Bonnet, and A.S. Nateri Embryonic NANOG activity defines colorectal cancer stem cells and modulates through AP1- and TCF-dependent mechanisms Stem Cells 30 2012 2076 2087
64. T. Ishiguro, A. Sato, H. Ohata, H. Sakai, H. Nakagama, and K. Okamoto Differential expression of nanog1 and nanogp8 in colon cancer cells Biochem. Biophys. Res. Commun. 418 2012 199 204
65. C.R. Jeter, M. Badeaux, G. Choy, D. Chandra, L. Patrawala, C. Liu, T. Calhoun-Davis, H. Zaehres, G.Q. Daley, and D.G. Tang Functional evidence that the self-renewal gene NANOG regulates human tumor development Stem Cells 27 2009 993 1005
66. C.R. Jeter, B. Liu, X. Liu, X. Chen, C. Liu, T. Calhoun-Davis, J. Repass, H. Zaehres, J.J. Shen, and D.G. Tang NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation Oncogene 30 2011 3833 3845
67. A.R. Palla, D. Piazzolla, M. Abad, H. Li, O. Dominguez, H.B. Schonthaler, E.F. Wagner, and M. Serrano Reprogramming activity of NANOGP8, a NANOG family member widely expressed in cancer Oncogene 2013 10.1038/onc.2013.196 Published online June 10, 2013
68. K. Uchino, G. Hirano, M. Hirahashi, T. Isobe, T. Shirakawa, H. Kusaba, E. Baba, M. Tsuneyoshi, and K. Akashi Human Nanog pseudogene8 promotes the proliferation of gastrointestinal cancer cells Exp. Cell Res. 318 2012 1799 1807
69. J. Zhang, L.A. Espinoza, R.J. Kinders, S.M. Lawrence, T.D. Pfister, M. Zhou, T.D. Veenstra, S.S. Thorgeirsson, and J.M. Jessup NANOG modulates stemness in human colorectal cancer Oncogene 32 2013 4397 4405
70. J. Zhang, X. Wang, B. Chen, Z. Xiao, W. Li, Y. Lu, and J. Dai The human pluripotency gene NANOG/NANOGP8 is expressed in gastric cancer and associated with tumor development Oncol Lett 1 2010 457 463
71. J. Zhang, X. Wang, M. Li, J. Han, B. Chen, B. Wang, and J. Dai NANOGP8 is a retrogene expressed in cancers FEBS J. 273 2006 1723 1730
72. S. Assou, T. Le Carrour, S. Tondeur, S. Ström, A. Gabelle, S. Marty, L. Nadal, V. Pantesco, T. Réme, and J.P. Hugnot et al. A meta-analysis of human embryonic stem cells transcriptome integrated into a web-based expression atlas Stem Cells 25 2007 961 973
73. M. Pardo, B. Lang, L. Yu, H. Prosser, A. Bradley, M.M. Babu, and J. Choudhary An expanded Oct4 interaction network: implications for stem cell biology, development, and disease Cell Stem Cell 6 2010 382 395
74. J. Sun, S.L. Zheng, F. Wiklund, S.D. Isaacs, G. Li, K.E. Wiley, S.T. Kim, Y. Zhu, Z. Zhang, and F.C. Hsu et al. Sequence variants at 22q13 are associated with prostate cancer risk Cancer Res. 69 2009 10 15